William Blair Investment Management LLC Sells 4,375,246 Shares of Acadia Healthcare Company, Inc. $ACHC

William Blair Investment Management LLC trimmed its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 99.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,309 shares of the company’s stock after selling 4,375,246 shares during the quarter. William Blair Investment Management LLC’s holdings in Acadia Healthcare were worth $529,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after purchasing an additional 1,234 shares in the last quarter. Covestor Ltd grew its stake in Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after purchasing an additional 812 shares in the last quarter. CWM LLC grew its stake in Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after purchasing an additional 1,349 shares in the last quarter. Signaturefd LLC grew its stake in Acadia Healthcare by 1,451.7% in the second quarter. Signaturefd LLC now owns 5,043 shares of the company’s stock valued at $114,000 after purchasing an additional 4,718 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in Acadia Healthcare by 1,120.3% in the second quarter. Parallel Advisors LLC now owns 5,174 shares of the company’s stock valued at $117,000 after purchasing an additional 4,750 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Raymond James Financial lifted their target price on Acadia Healthcare from $26.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday, October 3rd. Bank of America downgraded Acadia Healthcare from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $27.00 to $25.00 in a research note on Wednesday, September 10th. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. KeyCorp reduced their target price on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Finally, Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $35.09.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $23.96 on Tuesday. The stock has a market cap of $2.21 billion, a P/E ratio of 15.87, a PEG ratio of 4.79 and a beta of 0.90. The stock has a 50 day simple moving average of $23.21 and a 200 day simple moving average of $23.13. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $54.15.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. The business had revenue of $869.23 million during the quarter, compared to analysts’ expectations of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.